2012 Press Releases

Keyword Search
2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010
DateTitle 
12/27/12West Announces First Quarter 2013 Dividend
Dec 27, 2012 (Marketwire via COMTEX) --West Pharmaceutical Services, Inc. (NYSE: WST) today announced that its Board has approved the payment of a first-quarter 2013 cash dividend of $0.19 per share. The dividend will be paid on February 6, 2013 to shareholders of record on January 23, 2013. About West West is a global manufacturer of components and systems for injectable drug delivery, including stoppers and seals for vials, and closures and disposable components used in syringe, IV and b... 
Printer Friendly Version
11/06/12West to Present at Lazard Conference
Nov 06, 2012 (Marketwire via COMTEX) --West Pharmaceutical Services, Inc. (NYSE: WST) today announced that management will attend the Lazard Capital Markets 9th Annual Healthcare Conference in New York, NY. Management will present an overview of West's business and outlook on Tuesday, November 13, 2012 at 9:00 AM Eastern Time. A live audio webcast of the Company's presentation, as well as a copy of the presentation materials, will be accessible from the Company's website at www.westpharma.com... 
Printer Friendly Version
11/01/12West Announces Third Quarter Results, Increases 2012 EPS Guidance
Conference Call Scheduled for 9 a.m. Today Nov 01, 2012 (Marketwire via COMTEX) --West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the third quarter of 2012. Highlights Sales increased 3.5% (9.2% excluding currency) with continuing growth in order backlog. Diluted EPS of $0.43 includes restructuring and tax charges. Adjusted diluted EPS of $0.52, compared to $0.53 in the third quarter of 2011. ... 
Printer Friendly Version
10/25/12West to Host Third Quarter 2012 Conference Call
Oct 25, 2012 (Marketwire via COMTEX) -- West Pharmaceutical Services, Inc. (NYSE: WST) confirmed today that it will release third quarter 2012 financial results before the market opens on Thursday, November 1, 2012 and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time. To participate on the call please dial 866-356-4279 (U.S.) or 617-597-5394 (International). The confirmation number is 67327244. A live broadcast of the conference cal... 
Printer Friendly Version
10/11/12West Pharmaceutical Services to Share Insights and Showcase Solutions for Drug Delivery, Safety and Efficacy at PDA Conference and AAPS Annual Meeting
Experts will present best practices in integrating Quality by Design and human factors analysis into injectable drug delivery systems LIONVILLE, Pa., Oct. 11, 2012 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative system and component solutions for injectable drug administration, today announced that company representatives will be speaking in several educational sessions and showcasing West's innovations at the Parenteral Drug Association's Unive... 
Printer Friendly Version
10/01/12West Increases Quarterly Dividend to $0.19
Oct 01, 2012 (Marketwire via COMTEX) --West Pharmaceutical Services, Inc. (NYSE: WST) today announced that its Board of Directors has approved an increase of one cent per share in the Company's quarterly cash dividend, to $0.19 per share, beginning in the fourth quarter of 2012. The increase is the nineteenth consecutive annual increase in the Company's quarterly dividend. The fourth quarter dividend will be paid on November 7, 2012 to shareholders of record on October 24, 2012. About West ... 
Printer Friendly Version
09/11/12West Announces the Commercial Launch of the B.safe(TM) Syringe Safety System Technology Platform
LIONVILLE, Pa., Sept. 11, 2012 /PRNewswire via COMTEX/ --West (NYSE: WST), a leading global developer and manufacturer of components and systems for injectable drug delivery, announces the commercial introduction of its B.safe(TM) syringe safety system. West acquired the IP and rights to this system in 2011 and has completed the product development and first phase of commercial scale-up at its safety systems manufacturing center in France. Significant scale-up to high-volume manufacturing will b... 
Printer Friendly Version
09/05/12West to Present at Upcoming Investor Conferences
Sep 05, 2012 (Marketwire via COMTEX) --West Pharmaceutical Services, Inc. (NYSE: WST) today announced that management will participate in two upcoming investor conferences. Management will be presenting an overview of West's business and outlook at each of the following conferences: CL King 10th Annual Best Ideas Conference, New York, NY Wednesday, September 12, 2012 at 10:40 AM Eastern Time. UBS 2012 Global Life Sciences Conference, New York, NY Wednesday, September 19, 2012 at 4:00 PM E... 
Printer Friendly Version
09/04/12West Announces Agreement with Janssen Biotech to Develop and Commercialize a New Self-injection Technology
LIONVILLE, Pa., Sept. 4, 2012 /PRNewswire via COMTEX/ -- West (NYSE: WST), a leading global manufacturer of components and systems for injectable drug delivery, today announced an agreement with Janssen Biotech, Inc. to collaborate on the development and manufacturing of an innovative self-injection product. The technology, developed by Janssen Biotech, has been specifically designed to meet the needs of patients by facilitating easier self-injection of pharmaceutical and biologic drug products.... 
Printer Friendly Version
08/22/12West Breaks Ground on New Manufacturing Facility in India
LIONVILLE, Pa.--(BUSINESS WIRE)--Aug. 22, 2012-- Today, West Pharmaceutical India Packaging Private Ltd, an indirect subsidiary of West Pharmaceutical Services, Inc. (NYSE: WST), Lionville, Pa., USA, hosted a ground breaking ceremony to mark the start of construction of its new compression molding facility located in Sri City, India. The plant will become part of West's global supply chain for its world-class, standard-setting pharmaceutical packaging components. In June 2012, West signed a 99... 
Printer Friendly Version
08/02/12West Announces Record Second Quarter Results, Raises 2012 EPS Guidance
Aug 02, 2012 (Marketwire via COMTEX) --West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the second quarter of 2012.  Highlights Sales grew 5.5% (11.3% excluding currency) to a record $324.8 million. Reported diluted earnings per share of $0.45 included debt extinguishment and impairment charges. Adjusted diluted EPS of $0.79, compared to $0.62 in the second quarter of 2011. Raises 2012 Ad... 
Printer Friendly Version
07/26/12West to Host Second Quarter 2012 Conference Call
Jul 26, 2012 (Marketwire via COMTEX) --West Pharmaceutical Services, Inc. (NYSE: WST) confirmed today that it will release second quarter 2012 financial results before the market opens on Thursday, August 2, 2012 and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time. To participate on the call please dial 888-895-5271 (U.S.) or 847-619-6547 (International). The confirmation number is 32923811. A live broadcast of the conference call ... 
Printer Friendly Version
07/05/12West Announces Completion of Private Placement of Senior Debt Securities
LIONVILLE, PA, Jul 05, 2012 (MARKETWIRE via COMTEX) --West Pharmaceutical Services, Inc. (NYSE: WST) ("West") today announced that it has completed a private placement of $168 million senior unsecured notes (the "Notes") in a private placement exempt from registration under the Securities Act of 1933, as amended. Three series of Notes were issued as follows: Series, coupon, maturity Principal ------------------------------------- -----------... 
Printer Friendly Version
06/20/12West Announces Technology Agreement With Amgen
LIONVILLE, PA, Jun 20, 2012 (MARKETWIRE via COMTEX) --West Pharmaceutical Services, Inc. (NYSE: WST), a leading global manufacturer of components and systems for injectable drug delivery, today announced an agreement with Amgen Inc., a biotechnology pioneer and one of the world's leading independent biotechnology companies, to evaluate Daikyo Crystal Zenith(R) technologies for drug containment. These technologies were developed over many years by West's partner, Daikyo Seiko, Ltd., and are... 
Printer Friendly Version
06/06/12West Announces Expiration and Final Results of Cash Tender Offer for Any and All of Its 4.00% Convertible Junior Subordinated Debentures Due 2047
LIONVILLE, PA, Jun 06, 2012 (MARKETWIRE via COMTEX) --West Pharmaceutical Services, Inc. (NYSE: WST) today announced the expiration and final results of its previously announced tender offer (the "Offer") to purchase for cash any and all of its outstanding 4.00% Convertible Junior Subordinated Debentures Due 2047 (CUSIP No. 955306 AA 3) (the "Debentures"). The Offer expired at 12:00 midnight, New York City time, on June 5, 2012. As of the expiration of the Offer, $158,364,000 in aggregat... 
Printer Friendly Version
06/01/12West Announces Purchase Price for Cash Tender Offer for Any and All of Its 4.00% Convertible Junior Subordinated Debentures Due 2047
LIONVILLE, PA, Jun 01, 2012 (MARKETWIRE via COMTEX) --West Pharmaceutical Services, Inc. (NYSE: WST) today announced that it has determined the final purchase price offered pursuant to its previously announced tender offer (the "Offer") to purchase for cash any and all of its outstanding 4.00% Convertible Junior Subordinated Debentures Due 2047 (CUSIP No. 955306 AA 3) (the "Debentures"). The purchase price per $1,000 principal amount of Debentures is $1038.91. In addition, holders will r... 
Printer Friendly Version
05/25/12West to Present at Jefferies Conference
LIONVILLE, PA, May 25, 2012 (MARKETWIRE via COMTEX) --West Pharmaceutical Services, Inc. (NYSE: WST) today announced that management will attend the Jefferies 2012 Global Healthcare Conference in New York, NY. Management will present an overview of West's business and outlook on Monday, June 4, 2012 at 1:00 PM Eastern Time. A live audio webcast of the Company's presentation, as well as a copy of the presentation materials, will be accessible from the Company's website at www.westpharma.... 
Printer Friendly Version
05/10/12West to Host Analyst and Investor Day
LIONVILLE, PA, May 10, 2012 (MARKETWIRE via COMTEX) --West Pharmaceutical Services, Inc. (NYSE: WST) today announced that the company will host an Analyst and Investor Day for financial analysts on Wednesday, May 23, 2012 from 8:30 am to 11:30 EDT in New York, NY. Members of West's senior management will provide an overview of the company's current markets, operations, and growth opportunities. Presentations will begin at 9:00 am EDT. For additional information and registration, please e... 
Printer Friendly Version
05/08/12West to Present at Bank of America Merrill Lynch Conference
LIONVILLE, PA, May 08, 2012 (MARKETWIRE via COMTEX) --West Pharmaceutical Services, Inc. (NYSE: WST) today announced that management will attend the Bank of America Merrill Lynch 2012 Health Care Conference in Las Vegas, NV. Management will present an overview of West's business and outlook on Tuesday, May 15, 2012 at 3:40 PM Pacific Time (6:40 Eastern Time). A live audio webcast of the Company's presentation, as well as a copy of the presentation materials, will be accessible from the C... 
Printer Friendly Version
05/08/12West Announces Proposed Private Placement of Senior Debt Securities
LIONVILLE, PA, May 08, 2012 (MARKETWIRE via COMTEX) --West Pharmaceutical Services, Inc. (NYSE: WST) today announced that it intends to commence an offering of senior debt securities in a private placement (the "Private Placement") exempt from registration under the Securities Act of 1933, as amended (the "Securities Act"). West expects to undertake the Private Placement, subject to market conditions, after it commences a tender offer ("Offer"), which West will separately announce today, f... 
Printer Friendly Version
05/08/12West Announces Commencement of Cash Tender Offer for Any and All of Its 4.00% Convertible Junior Subordinated Debentures Due 2047
LIONVILLE, PA, May 08, 2012 (MARKETWIRE via COMTEX) --West Pharmaceutical Services, Inc. (NYSE: WST) today announced that it has commenced a cash tender offer to purchase for cash any and all of its outstanding 4.00% Convertible Junior Subordinated Debentures Due 2047 (CUSIP No. 955306 AA 3) (the "Debentures"). The tender offer (the "Offer") is being made upon the terms and subject to the conditions set forth in West's Offer to Purchase, dated May 8, 2012, and the related Letter of Transmi... 
Printer Friendly Version
05/02/12West Announces Third Quarter 2012 Dividend and Director Retirement
LIONVILLE, PA, May 02, 2012 (MARKETWIRE via COMTEX) --West Pharmaceutical Services, Inc. (NYSE: WST) today announced that its Board has approved the payment of a third-quarter 2012 cash dividend of $0.18 per share. The dividend will be paid on August 1, 2012 to shareholders of record on July 18, 2012. West also announced the retirement of Robert C. Young, M.D., from its board pursuant to the Company's director retirement policy. The size of the board was reduced to ten directors, elimina... 
Printer Friendly Version
04/26/12West Announces First Quarter 2012 Results, Revises 2012 Guidance
Conference Call Scheduled for 9 a.m. Today LIONVILLE, PA, Apr 26, 2012 (MARKETWIRE via COMTEX) --West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the first quarter of 2012. Highlights -- Adjusted Diluted EPS of $0.83(1), compared to $0.60(1) reported in the first quarter of 2011. -- Reported earnings per diluted share of $0.81, including restructuring, tax, and valuation items. -- Sales grew 9.1% in the quarter, excluding curren... 
Printer Friendly Version
04/20/12West to Host First Quarter 2012 Conference Call
LIONVILLE, PA, Apr 20, 2012 (MARKETWIRE via COMTEX) --West Pharmaceutical Services, Inc. (NYSE: WST) confirmed today that it will release first quarter 2012 financial results before the market opens on Thursday, April 26, 2012 and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time. To participate on the call please dial 800-901-5217 (U.S.) or 617-786-2964 (International). The passcode is 24965800. A live broadcast of the confere... 
Printer Friendly Version
04/17/12West Pre-Announces First Quarter 2012 Earnings per Share
Increases 2012 Earnings per Share Guidance -- Full Release and Analyst Call Scheduled for Thursday, April 26, 2012 LIONVILLE, PA, Apr 17, 2012 (MARKETWIRE via COMTEX) --West Pharmaceutical Services, Inc. (NYSE: WST) today announced that it expects first-quarter Adjusted Diluted EPS to be $0.83, compared to $0.60 in the first quarter of 2011, on sales growth of approximately 7% (9% excluding currency effects). Reported diluted earnings per share, which includes items excluded from Adjuste... 
Printer Friendly Version
04/16/12West Introduces New NovaPure(R) Components
Component manufacturing process designed with Quality by Design principles meets the high-quality needs of pharmaceutical manufacturers and patients PHOENIX, Apr 16, 2012 (BUSINESS WIRE) --Annual Meeting of the Parenteral Drug Association (PDA) -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today introduced a new line of high-quality components under its Nova... 
Printer Friendly Version
03/06/12West to Present at Barclays Capital Conference
LIONVILLE, PA, Mar 06, 2012 (MARKETWIRE via COMTEX) --West Pharmaceutical Services, Inc. (NYSE: WST) today announced that management will attend the Barclays Capital Global Healthcare Conference in Miami, FL. Management will present an overview of West's business and outlook on Tuesday, March 13, 2012 at 9:00 AM ET. A live audio webcast of the Company's presentation, as well as a copy of the presentation materials, will be accessible from the Company's website at www.westpharma.com/en/in... 
Printer Friendly Version
02/27/12West Elects New Director
Announces Second Quarter 2012 Dividend LIONVILLE, PA, Feb 27, 2012 (MARKETWIRE via COMTEX) --West Pharmaceutical Services, Inc. (NYSE: WST) today announced that its Board of Directors increased the size of the Board to eleven and elected William F. Feehery, Ph.D., to fill the vacancy. His term runs until the 2012 Annual Meeting of Shareholders and he has been nominated for re-election by shareholders at that meeting. The addition of Mr. Feehery will keep the Board at its previous streng... 
Printer Friendly Version
02/16/12West Announces Fourth Quarter 2011 Results, Provides 2012 Guidance
Conference Call Scheduled for 9 a.m. Today LIONVILLE, PA, Feb 16, 2012 (MARKETWIRE via COMTEX) --West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the fourth quarter and full year of 2011. Highlights -- Fourth-quarter 2011 Adjusted Diluted EPS of $0.59, sharply higher than $0.42 reported in the prior-year. -- Reports 6.8% sales growth in the quarter, net of unfavorable currency effects. -- Pricing, sales mix, and production effic... 
Printer Friendly Version
02/09/12West to Host Fourth Quarter and Full Year 2011 Conference Call
LIONVILLE, PA, Feb 09, 2012 (MARKETWIRE via COMTEX) --West Pharmaceutical Services, Inc. (NYSE: WST) announced today that it will release fourth quarter and full year 2011 financial results before the market opens on Thursday, February 16, 2012 and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time. To participate on the call please dial 800-299-6183 (U.S.) or 617-801-9713 (International). The passcode is 96457871. A live broadc... 
Printer Friendly Version
01/31/12West to Present at UBS Conference
LIONVILLE, PA, Jan 31, 2012 (MARKETWIRE via COMTEX) --West Pharmaceutical Services, Inc. (NYSE: WST) today announced that management will attend the UBS 22nd Annual Global Healthcare Services Conference in New York, NY. Management will present an overview of West's business and outlook on Tuesday, February 7, 2012 at 3:00 PM ET. A live audio webcast of the Company's presentation, as well as a copy of the presentation materials, will be accessible from the Company's website at www.westph... 
Printer Friendly Version
West Pharma Callout
Contact Investor Relations